Inthera Bioscience AG

The core activity of Inthera Bioscience AG is the development of therapies for previously incurable types of cancer, particularly through the selective destruction of cancer cells by replicative stress. The company covers the entire value creation process, from target discovery and validation to early drug development, medicinal chemistry, preclinical and toxicological work, as well as early clinical development.